|
Committee
on Veterans’ Affairs
Subcommittee
on Benefits
United
States House of Representatives
October
26, 1999
Invited Testimony by
Claudia S. Miller, M.D., M.S.
Environmental
and Occupational Medicine
Department
of Family Practice
The
University of Texas Health Science Center at San Antonio
7703
Floyd Curl Drive, San Antonio, Texas 78229-3900
Telephone:
(210) 567-7760; Fax: (210) 567-7764; Email: millercs@uthscsa.edu
I
have been asked to explain how physicians who see sick Gulf War
veterans can observe the same or similar symptoms and interpret them
as either undiagnosed illness or diagnosed illness. Even when doctors
apply monikers to these patients' illnesses, like depression, migraine
headaches, asthma, irritable bowel or fibromyalgia, these monikers do
not explain why these
veterans are sick. Most have symptoms involving several organ systems
simultaneously. For them
there is no unifying diagnosis offered, no etiology specified, and no
disease process clarified.
In
truth, all of these veterans are undiagnosed because what we are
dealing with is an entirely new mechanism of disease not covered by
standard medical diagnoses -- one which presents itself
symptomatically as different conditions to different specialists.
The
rheumatologist observing diffuse muscle pain diagnoses myalgias.
The
neurologist hearing head pain and nausea diagnoses migraine headaches.
The
pulmonologist finding airway reactivity diagnoses asthma.
The
psychiatrist seeing chronic malaise diagnoses depression.
The
gastroenterologist noting GI complaints diagnoses irritable bowel
syndrome.
Some
private practitioners diagnose multiple chemical sensitivity, or MCS,
which is not a diagnosis in itself, but rather just another
manifestation of the underlying disease process.
So
what is at the core of this myriad of symptoms that has come to be
called “Gulf War Syndrome?” What is the underlying disease
process? The key is in the new-onset intolerances these people share.
Over
the past six years, I have served as a consultant to the VA's referral
center for Gulf War veterans in Houston. The vast majority of the
veterans there reported multiple new intolerances since the War. Among
the first 59 patients, 78% reported new-onset chemical intolerances;
40% experienced adverse reactions to medications; 78% described new
food intolerances; 66% reported that even a can of beer made them feel
ill; 25 percent became ill after drinking caffeinated beverages; and
74 percent of smokers felt sick if they smoked an extra cigarette or
borrowed someone else's stronger brand. More than half reported new
intolerances in all three categories -- chemical inhalants, foods, and
drugs or food/drug combinations.
One
mechanic said that before the Gulf War his idea of the perfect perfume
was WD-40. Since the war, WD-40 and a host of other chemicals make him
feel ill. Many veterans no longer fill their own gas tanks because the
gasoline vapors make them "spacy" or sick. Some won't drive
because they become disoriented in traffic and they fear causing an
accident. Or they can't find their cars, forget where they are going
or get lost in once familiar areas. One VA study found excess motor
vehicle deaths among Gulf veterans and interpreted this as possible
increased risk-taking behavior (Kang and Bullmann, 1996). What the
veterans tell me is that they get confused, go off the road, mistake
the accelerator for the brake, and have trouble judging stopping
distances when they are exposed to gasoline, diesel exhaust, or
freshly tarred roads.
Researchers
at the Robert Wood Johnson Medical School in New Jersey and at the
University of Arizona have noted similar multi-system symptoms and
intolerances to common chemicals, foods, and drugs among the veterans
(Fiedler et al, 1996; Bell et al, 1998). And a CDC study found that
ill Gulf War veterans reported more chemical intolerances than healthy
veterans (Fukuda et al, 1998).
These
studies are confounded by a phenomenon called "masking,"
which occurs when people become intolerant to many different things
(Miller and Prihoda, 1999a). As they go through a day, symptoms
triggered by fragrances, hairspray, vehicle exhaust, foods and
medications pile up so they feel sick most of the time. No one cause
can be isolated because there's too much background noise, and
patients often underestimate the number of exposures that affect them.
This
problem is not altogether new. German researchers described similar
intolerances in chemical weapons workers after World War II (Spiegelberg,
1961). Nearly 20 percent of agricultural workers on a California
registry for organophosphate pesticide poisoning (Tabershaw and
Cooper, 1966) reported that even a "whiff" of pesticide made
them sick with symptoms like those of the Gulf War veterans, as did
dozens of government workers a decade ago, after the EPA headquarters
became a "sick building" following remodeling (EPA, 1989).
Similar outbreaks of chemical intolerances have been reported in more
than a dozen countries (Ashford et al, 1995).
These
observations suggest that we may indeed be dealing with an entirely
new mechanism for disease, one which has been referred to with the
acronym “TILT”, or "Toxicant-induced Loss of Tolerance"
(Miller, 1996, 1997, 1999). Any one toxicant appears capable of
initiating this process. TILT involves two steps, initiation and
triggering (Ashford and Miller, 1998): (1) First, a single acute or
multiple low-level exposures to a pesticide, solvent or other chemical
causes loss of tolerance in a subset of those exposed; (2) Thereafter
very low levels of common substances can trigger symptoms -- not only
chemicals, but various foods, medications, alcoholic beverages and
caffeine. Symptoms involve several organ systems. These intolerances
are the hallmark of TILT, just as fever is the hallmark symptom of
infectious diseases.
Over
the past several years, the finger has been pointed at a number of
potential causes for Gulf War Syndrome -- everything from the oil
shroud to pesticides, vaccinations, and pyridostigmine bromide.
What set off the Gulf War Veterans? The answer is "all of
the above." Exposure to any one or any combination of these
toxicants may, in fact, be capable of causing a general breakdown in
tolerance that can result in a plethora of beguiling symptoms.
We
do not know exactly how this breakdown in tolerance occurs. We do know
that rats with nervous systems sensitive to organophosphate pesticides
are also intolerant of diverse drugs and have increased gut
permeability which in humans is associated with food intolerance
(Overstreet et al, 1996). This suggests the breakdown might involve
the cholinergic nervous system, which regulates processes throughout
the body.
How
can these people be helped? No one knows -- yet. The biggest obstacle
is the symptoms themselves, which serve as red herrings, diverting
attention away from the central problem. What we do know is that Gulf
War veterans, who have come to recognize what sets them off and then
avoid these triggers, tend to improve. We need to apply this
understanding to the diagnosis and treatment of other such veterans.
The
first thing that needs to be done is to set up unmasking
studies in which sick Gulf War veterans can be isolated from the
exposures that are setting them off. This can be achieved by putting
them in a special environmentally controlled hospital unit (Miller,
1997; Miller et al, 1997). Once we get them to baseline, we can
reintroduce things like caffeine, perfumes, various foods, etc., and
identify some of the things that cause their flare-ups. With
avoidance, it is hoped that they, too, can improve.
This combined diagnostic-therapeutic approach would eliminate
much of the confusion that is the focus of this hearing.
There
is no simple answer to Gulf War illness. No single toxicant is likely
to have caused it. But if we concentrate less on the original
toxicants and more on the underlying disease mechanism, I believe we
can make progress in understanding why these people are sick and what
we can do to help them.
REFERENCES
Agency
for Toxic Substances and Disease Registry
(ATSDR) (1994). Proceedings
of the Conference on low
level exposure to chemicals
and neurobiologic sensitivity.
Tox. Ind. Health 10(4/5):25.
Ashford,
N., Heinzow, B., Lütjen, K., Marouli, C., Mølhave, L., Mönch, B.,
Papadopoulos, S., Rest, K., Rosdahl, D., Siskos,
P., and Velonakis, E.
(1995). “Chemical sensitivity
in Selected European Countries: An Exploratory Study.” Ergonomia
Ltd., Athens, Greece.
Ashford,
N.,
and Miller, C. (1998).
Chemical Exposures: Low Levels and High Stakes. New York, Wiley &
Sons.
Bell,
I., Walsh, M., Gross, a., Gersmeyer, j., schwartz, g.,
and kanof, P. (1997).
“Cognitive Dysfunction and Disability in Geriatric Veterans with
Self-Reported Intolerance to Environmental Chemicals.” J. Chronic
Fatigue Syndrome. 3(3):15- 42.
Environmental
Protection Agency
(EPA) (1989). Report to Congress on Indoor Air Quality, Volume II,
Assessment and Control of Indoor Air Pollution.
Fiedler,
N., Kipen, H., Natelson,
B., and Ottenweller, J.
(1996). “Chemical Sensitivities and the Gulf War: Department of
Veterans Affairs Research Center in Basic and Clinical Science Studies
of Environmental Hazards.” Regulatory Tox. Pharmacol. 24: S129-S138.
Fukuda,
K., Nisenbaum, R., Stewart, G., thompson, W., robin, L., Washko, R.,
Noah, D., Barrett, D., Randall, B., Herwaldt, B., Mawle, A., and Reeves, W. (1998). “Chronic multi-system illness
affecting Air Force veterans
of the Gulf War.” JAMA
280: 981-988.
kang,
H., and bullman, T.
(1996). “Mortality among
U.S. Veterans of the Persian Gulf War.” New Engl. J. Med.
335(2a):1498-1504.
Miller,
C. (1996). “Chemical Sensitivity: Symptom, Syndrome or Mechanism for
Disease?” Tox. 11: 69-86.
Miller,
C. (1997). “Toxicant-Induced Loss of Tolerance—An Emerging Theory
of Disease?” Environ. Health Perspect. 105 (Suppl. 2): 445-453.
Miller,
C. (1999). “Are We on the Threshold of a New Theory of Disease?
Toxicant-induced Loss of Tolerance and its Relationship to
Addiction and Abdiction” Tox. Ind. Health. 15:284-294.
Miller,
C., and Prihoda, T.
(1999a). “A Controlled Comparison of Symptoms and Chemical
Intolerances Reported by Gulf War Veterans, Implant Recipients and
Persons with Multiple Chemical Sensitivity.” Tox. Ind. Health
15:386-397.
Miller,
C., and Prihoda, T.
(1999b). “The Environmental Exposure and Sensitivity Inventory (EESI):
A Standardized approach for measuring Chemical Intolerances for
Research and Clinical Applications.” Tox. Ind. Health 15:370-385.
Miller,
C., Ashford, N., Doty, R.,
Lamielle, M., Otto, D., Rahill, A., and Wallace,
L. (1997). “Empirical Approaches for the Investigation of
Toxicant-Induced Loss of Tolerance.” Environ. Health Perspect. 105 (Suppl.
2): 515-519.
Overstreet,
D., Miller, C., Janowsky,
D., and
Russell, R. (1996). “Potential Animal Model of Multiple
Chemical Sensitivity with Cholinergic Supersensitivity.” Tox. 111:
119-134.
Spiegelberg,
V. (1961). “Psychopathologisch-neurologische Schāden nach
Einwirkung Synthetischer Gifte.”
In Wehrdienst und Gesundeir, Vol. III.
Darmstadt: Wehr und Wissen Verlagsgessellshaft (1961).
Tabershaw,
I., and Cooper, C.
(1966). “Sequelae of Acute Organic Phosphate Poisoning” J. Occup.
Med. 8:5-20.
BIOSKETCH
Claudia
S. Miller, M.D., M.S., is an Associate Professor in Environmental and
Occupational Medicine in the Department of Family Practice of the
University of Texas Health Science Center at San Antonio.
Board-certified in Allergy/Immunology and Internal Medicine,
she holds a Master’s degree in Public Health/Environmental Health.
Her research interests include the health effects of low level
chemical exposures, pesticides, indoor air pollution, and Gulf War
veterans’ illnesses. Dr.
Miller has held appointments to several federal advisory committees,
including the National Advisory Committee on Occupational Safety and
Health, the National Toxicology Program Board of Scientific
Counselors, and the Department of Veterans Affairs Persian Gulf Expert
Scientific Advisory Committee. She
is co-author of the WHO-award-winning New
Jersey Report on Chemical Sensitivity and a professionally
acclaimed book, Chemical
Exposures: Low Levels and High Stakes.
Other support related to
these proceedings: Dr. Miller has served as a consultant to the
Houston VA Regional Referral Center for Gulf War Veterans since 1993.
She is also principal investigator on a study of
neurobehavioral sensitization funded by the Office of Naval Research.
Back to Witness
List |